Amit Sachdev Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Amit Sachdev has an estimated net worth of at least $38.2 million*, as of Oct. 29, 2025. They own 58,934 shares of VRTX stock. They have sold 81,275 shares of VRTX stock since 2021, for an estimated $8.0 million.
Amit Sachdev $VRTX SEC Form 4 Insider Trading
Amit Sachdev has filed a total of 17 insider trades in $VRTX since 2021. Their most recent trade was a sale of 1,846 shares, made on Feb 25, 2026. Their largest trade was a sale of 19,662 shares, made on Feb 19, 2026. We estimate that they now own 58,934 shares of $VRTX, worth an estimated $30.2 million.
Insider Trading at $VRTX
There have been a total of 557 insider trades reported at $VRTX since 2021, with 40,000 shares purchased and 1.1 million shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Ourania Tatsis, and Bastiano Sanna. The most recent trade was a sale of 260 shares reported by Ourania Tatsis (EVP, Chief Reg. & Quality Off.), made on Feb 25, 2026.
History of Insider Stock Trades by Amit Sachdev
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VRTX
|
Sale | 1,846 | Feb 25, 2026 | Feb. 26, 2026, 7:50 p.m. |
|
VRTX
|
Sale | 2,730 | Feb 19, 2026 | Feb. 23, 2026, 5:21 p.m. |
|
VRTX
|
Sale | 1,848 | Feb 19, 2026 | Feb. 23, 2026, 5:21 p.m. |
|
VRTX
|
Sale | 10,263 | Feb 19, 2026 | Feb. 23, 2026, 5:21 p.m. |
|
VRTX
|
Sale | 19,662 | Feb 19, 2026 | Feb. 23, 2026, 5:21 p.m. |
|
VRTX
|
Sale | 7,241 | Feb 19, 2026 | Feb. 23, 2026, 5:21 p.m. |
|
VRTX
|
Sale | 11,712 | Feb 19, 2026 | Feb. 23, 2026, 5:21 p.m. |
|
VRTX
|
Sale | 4,237 | Feb 19, 2026 | Feb. 23, 2026, 5:21 p.m. |
|
VRTX
|
Sale | 920 | Feb 19, 2026 | Feb. 23, 2026, 5:21 p.m. |
|
VRTX
|
Sale | 32 | May 15, 2024 | May 17, 2024, 4:27 p.m. |
|
VRTX
|
Sale | 3,191 | Feb 21, 2024 | Feb. 23, 2024, 5:20 p.m. |
|
VRTX
|
Sale | 4,254 | Feb 20, 2024 | Feb. 21, 2024, 5:38 p.m. |
|
VRTX
|
Sale | 3,222 | Feb 12, 2024 | Feb. 13, 2024, 6:15 p.m. |
|
VRTX
|
Sale | 35 | Nov 15, 2023 | Nov. 17, 2023, 5:16 p.m. |
|
VRTX
|
Sale | 10,031 | Aug 10, 2023 | Aug. 14, 2023, 4:05 p.m. |
|
VRTX
|
Sale | 21 | Nov 15, 2021 | Nov. 16, 2021, 5:07 p.m. |
|
VRTX
|
Sale | 30 | Nov 15, 2021 | Nov. 16, 2021, 5:07 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Stuart A Arbuckle, EVP, COO
-
Jeffrey M Leiden, Executive Chairman
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Reshma Kewalramani, CEO & President
-
Joy Liu, SVP, General Counsel
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Jonathan Biller, EVP and Chief Legal Officer
-
Carmen Bozic, EVP and CMO
-
David Altshuler, EVP, Chief Scientific Officer
-
Mark E. Bunnage, EVP, Chief Scientific Officer
-
Amit Sachdev, EVP, Chief Patient Officer
-
Charles F Jr Wagner, EVP, CO & FO
-
Duncan Mckechnie, EVP, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.